國(guo)藥(yao)(yao)(yao)(yao)集(ji)團(tuan)一(yi)致(zhi)(zhi)藥(yao)(yao)(yao)(yao)業(ye)(ye)股(gu)份有(you)(you)(you)限公司(si)(si)(si)(簡稱國(guo)藥(yao)(yao)(yao)(yao)一(yi)致(zhi)(zhi))國(guo)藥(yao)(yao)(yao)(yao)集(ji)團(tuan)一(yi)致(zhi)(zhi)藥(yao)(yao)(yao)(yao)業(ye)(ye)股(gu)份有(you)(you)(you)限公司(si)(si)(si) (簡稱國(guo)藥(yao)(yao)(yao)(yao)一(yi)致(zhi)(zhi))是中(zhong)國(guo)醫藥(yao)(yao)(yao)(yao)集(ji)團(tuan)有(you)(you)(you)限公司(si)(si)(si)、國(guo)藥(yao)(yao)(yao)(yao)控(kong)股(gu)股(gu)份有(you)(you)(you)限公司(si)(si)(si)旗下(xia)綜合性醫藥(yao)(yao)(yao)(yao)上市(shi)(shi)公司(si)(si)(si)(A股(gu)000028,B股(gu)200028),是國(guo)藥(yao)(yao)(yao)(yao)集(ji)團(tuan)全國(guo)醫藥(yao)(yao)(yao)(yao)零售整合平臺(tai),業(ye)(ye)務涵蓋“藥(yao)(yao)(yao)(yao)品分銷(xiao)+醫藥(yao)(yao)(yao)(yao)物流+醫藥(yao)(yao)(yao)(yao)零售+工業(ye)(ye)投(tou)資”全產業(ye)(ye)鏈條,下(xia)屬子公司(si)(si)(si)達(da)到110家,員工30000多人。承擔著中(zhong)央(yang)、省(廣(guang)東、廣(guang)西)、市(shi)(shi)(廣(guang)州、深圳(zhen)、南寧等)藥(yao)(yao)(yao)(yao)械商(shang)品特種儲備及全國(guo)各地所需搶險救災藥(yao)(yao)(yao)(yao)品調(diao)撥和(he)供應任務。
國(guo)藥(yao)(yao)一致在藥(yao)(yao)品分銷(xiao)(xiao)領域,立(li)足于打造“卓越的(de)(de)醫療供(gong)(gong)應(ying)鏈解決方案及(ji)(ji)服(fu)務(wu)提(ti)供(gong)(gong)商”,以集成(cheng)化、規模化的(de)(de)產業(ye)優勢,在中(zhong)(zhong)國(guo)南(nan)區(qu)形成(cheng)強大(da)的(de)(de)商業(ye)網(wang)絡。截止目前,公(gong)司在廣(guang)州、深(shen)(shen)圳、佛(fo)山、東莞、等兩廣(guang)重湛江、梅(mei)州、惠州、肇慶(qing)、江門(men)、韶關、中(zhong)(zhong)山、南(nan)寧、柳州要(yao)區(qu)域擁有47家(jia)子公(gong)司,實現在中(zhong)(zhong)國(guo)南(nan)區(qu)的(de)(de)深(shen)(shen)度滲透(tou)。公(gong)司構(gou)(gou)建(jian)起(qi)由區(qu)域物(wu)流(liu)中(zhong)(zhong)心、省級物(wu)流(liu)中(zhong)(zhong)心、城市(shi)配送(song)中(zhong)(zhong)心及(ji)(ji)配送(song)站組(zu)成(cheng)的(de)(de)“四(si)位一體”階梯式物(wu)流(liu)配送(song)網(wang)絡,拓(tuo)展多倉運營、第三方物(wu)流(liu)、冷(leng)鏈管理(li)等現代物(wu)流(liu)運作的(de)(de)新模式,為客戶及(ji)(ji)供(gong)(gong)應(ying)商提(ti)供(gong)(gong)有效(xiao)、快捷的(de)(de)藥(yao)(yao)品配送(song)及(ji)(ji)物(wu)流(liu)增(zeng)值服(fu)務(wu)。此外(wai),公(gong)司還積極(ji)推動(dong)業(ye)務(wu)轉型(xing)升級,著力推進全國(guo)零(ling)售終端業(ye)務(wu),打造全國(guo)零(ling)售直銷(xiao)(xiao)商業(ye)平臺(tai)。采用(yong)先進的(de)(de)供(gong)(gong)應(ying)鏈管理(li)方法和現代技術,開展器械業(ye)務(wu),拓(tuo)展4D業(ye)務(wu),打造SPD核心競(jing)爭力,攜手醫療機構(gou)(gou)開展供(gong)(gong)應(ying)鏈管理(li)延伸,實現降費增(zeng)效(xiao)。2019年底,分銷(xiao)(xiao)銷(xiao)(xiao)售收入(ru)超400億。
國(guo)(guo)藥(yao)一(yi)致(zhi)在藥(yao)品零(ling)(ling)(ling)售(shou)(shou)領(ling)域,攜(xie)(xie)手全(quan)球以藥(yao)店(dian)為(wei)主導的世界醫(yi)藥(yao)保健企業沃(wo)博聯,打造消(xiao)費者放心的中(zhong)國(guo)(guo)醫(yi)藥(yao)健康(kang)零(ling)(ling)(ling)售(shou)(shou)品牌(pai)“國(guo)(guo)大(da)藥(yao)房”。目(mu)前,已在全(quan)國(guo)(guo)21個省、自治(zhi)區(qu)、直轄市(shi)建立(li)了27家區(qu)域連鎖公司,覆蓋全(quan)國(guo)(guo)75各地級城(cheng)市(shi),擁(yong)有(you)超過(guo)5000家零(ling)(ling)(ling)售(shou)(shou)藥(yao)店(dian)。六年來穩居中(zhong)國(guo)(guo)醫(yi)藥(yao)零(ling)(ling)(ling)售(shou)(shou)行業首位(wei)。依托先(xian)進的管理能力、有(you)效快捷(jie)的采購體系(xi)、嚴格的質(zhi)量管控、精細(xi)的門(men)店(dian)管理、貼心的慢病服務(wu)、有(you)效的物流體系(xi)、全(quan)國(guo)(guo)ERP平臺(tai)等一(yi)系(xi)列優(you)勢,局涵(han)蓋中(zhong)藥(yao)、西(xi)藥(yao)、中(zhong)醫(yi)、西(xi)醫(yi)、康(kang)復理療與各類醫(yi)療相關資源的零(ling)(ling)(ling)售(shou)(shou)診療門(men)店(dian),創新應用“互聯網+”技術,攜(xie)(xie)手各地政府開展(zhan)在線社(she)區(qu)健康(kang)建設,保障人民健康(kang)需求(qiu)。2019年,國(guo)(guo)大(da)藥(yao)房銷(xiao)售(shou)(shou)收入(ru)超120億元。
國藥(yao)一致工業(ye)投資戰(zhan)略主要參股工業(ye)企業(ye)國藥(yao)致君深圳(zhen)制藥(yao)有限公(gong)(gong)司、國藥(yao)致君深圳(zhen)坪山制藥(yao)有限公(gong)(gong)司、深圳(zhen)致君醫藥(yao)貿易有限公(gong)(gong)司、深圳(zhen)萬樂(le)藥(yao)業(ye)有限公(gong)(gong)司,覆蓋抗(kang)感染、呼吸系統用藥(yao)、保健品、中成(cheng)藥(yao)及抗(kang)腫瘤藥(yao)等(deng)領域的研發、生產及銷售。2019年,工業(ye)投資板塊銷售額超40億元。
未(wei)來,國藥(yao)一致將繼續秉承“關愛生命 呵護健(jian)康(kang)(kang)(kang)”的(de)理念,立足中國醫(yi)藥(yao)健(jian)康(kang)(kang)(kang)產業發展機遇,轉型創(chuang)新(xin)(xin),深度發揮分銷和零售(shou)資源協同效應,推進(jin)(jin)批零一體戰(zhan)略(lve)和國際(ji)化(hua)(hua)戰(zhan)略(lve),以科技創(chuang)新(xin)(xin)推進(jin)(jin)公司數(shu)字化(hua)(hua)轉型,向著國際(ji)化(hua)(hua)醫(yi)藥(yao)健(jian)康(kang)(kang)(kang)服務平(ping)臺(tai)和更高規模目標邁進(jin)(jin)!